Inhibition of N-linked glycosylation of P-glycoprotein by tunicamycin results in a reduced multidrug resistance phenotype

Br J Cancer. 1995 Apr;71(4):670-5. doi: 10.1038/bjc.1995.133.

Abstract

Characterisation of altered glycosylation of P-glycoprotein (P-gp) found associated with the absence of a multidrug resistance (MDR) phenotype in cell lines prompted an investigation to assess the role of post-translational processing in establishing P-gp efflux pump functionally. The clone A cell line used in this study displays a strong MDR phenotype mediated by high constitutive levels of expression of P-gp. Incubation of clone A cells with tunicamycin for different periods resulted in a time-dependent increase in daunorubicin accumulation, reflecting a reduction in P-gp function. Parallel experiments conducted with verapamil resulted in no loss of P-gp functionality in clone A cells. Reduction in surface-associated P-gp following exposure to tunicamycin was established by FACS analysis, Western blot analysis and immunoprecipitation of surface-iodinated P-gp. In addition, immunoprecipitation of P-gp from 32P-orthophosphate-labelled cells demonstrated reduced phosphorylation of P-gp associated with tunicamycin exposure. From these studies we conclude that glycosylation of P-gp is required to establish the cellular MDR phenotype.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / biosynthesis*
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / isolation & purification
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism
  • Blotting, Western
  • Cell Line
  • Cell Membrane / metabolism
  • Colorectal Neoplasms
  • Drug Resistance, Multiple*
  • ErbB Receptors / isolation & purification
  • ErbB Receptors / metabolism
  • Flow Cytometry
  • Glycosylation / drug effects
  • Humans
  • Phenotype
  • Phosphorylation
  • Protein Processing, Post-Translational / drug effects*
  • Tumor Cells, Cultured
  • Tunicamycin / pharmacology*

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Tunicamycin
  • ErbB Receptors